Login / Signup
Interpreting Nonrandomized Clinical Trial Data in Low-Grade Sarcoma: Differentiating Clinical Benefit From Indolent Disease Is Key.
Evan Rosenbaum
Sujana Movva
Ciara M Kelly
Published in:
JCO precision oncology (2022)
Keyphrases
</>
low grade
clinical trial
high grade
electronic health record
big data
phase ii
study protocol
contrast enhanced
randomized controlled trial
magnetic resonance imaging
magnetic resonance
phase iii
computed tomography
artificial intelligence